<PAGE> 1
FORM 10-C
Securities and Exchange Commission
Washington, DC 20549
Report by issuer of securities quoted on The Nasdaq Stock Market (SM), filed
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and
Rule 13a-17 or 15d-17 thereunder.
Exact name of issuer as specified in charter: BioSource International, Inc.
---------------------------------
Address of principal executive offices: 820 Flynn Road, Camarillo, CA 93102
---------------------------------------
Issuer's telephone number (including area code): (805) 987-0086
------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:
1. Title of security Common Stock
----------------------------------------------------------
2. Number of shares outstanding before the change 5,918,003
-----------------------------
3. Number of shares outstanding after the change 8,310,003
------------------------------
4. Effective date of change June 5, 1996
---------------------------------------------------
5. Method of change Public Offering of Common Stock
-----------------------------------------------------------
Specify method (such as merger, acquisition, exchange, distribution, stock
split, acquisition of stock for treasury, etc.)
--------------------------------
Give brief description of transaction
-----------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change N/A
-------------------------------------------------------
2. Name after change
----------------------------------------------------------
3. Effective date of charter amendment changing name
--------------------------
4. Date of shareholder approval of change, if required
------------------------
6/10/1996 /s/ Anna Anderson, Chief Financial Officer
- -------------------------------------------------------------------------------
Date Officer's Signature and Title
